Efficacy and Safety of Regorafenib Monotherapy among Patients with Previously Treated Metastatic Colorectal Cancer in a Chinese Population: A Real-World Exploratory Study.

Int J Gen Med · 2021 · PMC8434851 · PMID 34522132

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

It should be noted that patients with right-sided colon cancer showed a trend of shorter PFS than those with left-sided CRC (1.8 vs 2.9 months), though the difference was not statistically significant ( P =0.056).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.